Market Currents
Cameron (CAM) - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA...
-
Monday, April 23, 2012, 10:56 AM ETCameron (CAM) - soon to be bought by Boston Scientific (BSX) - is -2.6% after FDA reviewers say they won't OK the firm's defibrillator until it resolves problems of the battery depleting too quickly. The reviewers also say the product, which is inserted under the skin, may have more infection issues and work slower than similar devices placed in the heart.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 2 comments:
I never would have thought.